Xiang Gao

19PUBLICATIONS
29CO-AUTHORS
Toxicology (incl. clinical toxicology)Epigenetics (incl. genome methylation and epigenomics)Rheumatology and arthritisFood properties (incl. characteristics and health benefits)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 21, 2026
Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial.

|Dec 05, 2025
Development and Validation of a Sensitive LC-MS/MS Method for Determination of Deoxythioguanosine in Human DNA and its Application in Thiopurine-Treated Inflammatory Bowel Disease Patients.

Jun-Tao Zheng, Jia-He Kong, Ting Yang

|Nov 03, 2025
Real-World Effectiveness and Patient Stratification for Vedolizumab Treatment in Crohn's Disease: A Multicenter Retrospective Study.

Kang Chao, Zhaopeng Huang, Hongsheng Yang

|Mar 23, 2025
Dietary whey protein protects against Crohn's disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome.

Runping Su, Weijie Wen, Yufeng Jin

|Feb 20, 2025
Risk factors and clinical characteristics of Clostridium difficile colonization and infection in patients with inflammatory bowel disease exposed to Vedolizumab: a multicenter retrospective study.

Qing Li, Xiaomei Song, Peizhu Su

|Dec 22, 2024
Clinical decision support tool-guided, selective intensive induction strategy of ustekinumab in patients with Crohn's disease: A multicenter cohort study.

Qing Li, Jian Tang, Zhao Peng Huang

Pageof 4

Frequent Collaborators

5 joint publications

Kang Chao

3 joint publications

Jian Tang

3 joint publications

Qin Guo

2 joint publications

Tao Zuo